Melnick L, Barst RJ, Rowan CA et al.
Columbia University College of Physicians and Surgeons, New York, NY, USA.
Am J Cardiol 2010;105:1285–9.
Editor’s note: The present authors describe a single center’s experience in transitioning pediatric patients from stable epoprostenol therapy to oral therapy. The approach is conservative, but is also shown to be safe.